NATION Vaccinated by Covaxin, might not be allowed to travel abroad Those who are fully vaccinated by the two doses of covaxin might not be allowed to travel abroad as the vaccine as the vaccine produced by Bharat Biotech has not been included in World Health Organization’s (WHO) Emergency Use Listing (EUL) yet, according to a report by LiveHindustan.
HEALTH Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt Covaxin received the Drugs Controller General of India's (DCGI) nod to conduct clinical trials in children on May 11.
CURRENT AFFAIRS Vaccine makers invited to produce Covaxin to scale up production Amid the reports of coronavirus vaccine shortage from various states, the Central government and Hyderabad-based Bharat Biotech are willing to invite other companies which want to produce COVAXIN in a bid to scale up the vaccine production, said NITI Aayog member, Dr VK Paul, on Thursday.
CURRENT AFFAIRS Delhi has run out of Covaxin stock for 18-44 age group: AAP MLA Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to shut 125 centres where the coronavirus vaccine was being administered, AAP MLA Atishi said on Tuesday.
NATION Bharat Biotech to make 6 crore Covaxin doses by May-July. The production of Covaxin will be doubled by May-July . The Bharat Biotech will produce 6 crore Covaxin vaccine doses.
CURRENT AFFAIRS Maharashtra gets nod to produce Covaxin at Haffkine Maharashtra government raised a demand with prime minister to allow the state to manufacture the Covaxin developed by Bharat Biotech.
HEALTH Serum Institute's 2nd COVID-19 vaccine likely to be launched in September: CEO Serum Institute of India's CEO Adar Poonawalla, on Saturday, said his company hopes to launch the second vaccine against Covid-19 by September this year.
/dnp-english/media/agency_attachments/2024/11/25/2024-11-25t064936166z-dnp-india-logo-640x480-dnp-news-2.png){kind=logo}